KNC Laboratories , Ltd. Receivables

KNC Laboratories , Ltd. (6568.T) currently reports a receivables of $1.3B as of June 2026. That compares with $870M in the prior-year period — up 52.4% year over year. Use the charts on this page to explore KNC Laboratories , Ltd.'s receivables history and peer comparisons.

KNC Laboratories , Ltd.'s receivables increased from $870M to $1.3B — a 52.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

KNC Laboratories , Ltd. reported $1.3B in receivables as of June 2026. That compares with $870M in the prior-year period — up 52.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for KNC Laboratories , Ltd., and consider following 6568.T for alerts when major investors trade the stock.